US52490G1022
US52490G1022
Legend Biotech Corporation
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.028.900.000 | 627.300.000 | 64.0% |
| Cost of Revenue | 408.100.000 | 234.600.000 | 74.0% |
| Gross Profit | 620.800.000 | 392.700.000 | 58.1% |
| 757.300.000 | 702.200.000 | 7.8% | |
| Operating Income | -136.500.000 | -309.500.000 | 55.9% |
| Pretax Income | -282.600.000 | -158.100.000 | 78.7% |
| Net Income Common Stockholders | -296.800.000 | -177.000.000 | 67.7% |
| -- | -- | -- | |
| -- | -- | -- |